IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 312 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $817,369 | -32.7% | 17,150 | -38.8% | 0.12% | -25.3% |
| Q1 2024 | $1,214,970 | +44.7% | 28,027 | +68.9% | 0.15% | -5.5% |
| Q4 2023 | $839,693 | +404.4% | 16,598 | +352.3% | 0.16% | +239.6% |
| Q3 2023 | $166,471 | +116.4% | 3,670 | +95.7% | 0.05% | +100.0% |
| Q2 2023 | $76,931 | +11.1% | 1,875 | -3.2% | 0.02% | +4.3% |
| Q1 2023 | $69,228 | +27.0% | 1,937 | +34.2% | 0.02% | +4.5% |
| Q4 2022 | $54,502 | -7.6% | 1,443 | +8.6% | 0.02% | -12.0% |
| Q3 2022 | $59,000 | – | 1,329 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sicart Associates LLC | 367,360 | $14,768,000 | 10.67% |
| BB BIOTECH AG | 7,461,295 | $299,944,000 | 9.81% |
| TANAKA CAPITAL MANAGEMENT INC | 83,399 | $3,353,000 | 7.39% |
| DOWLING & YAHNKE LLC | 675,843 | $27,169,000 | 2.89% |
| Opus Point Partners Management, LLC | 78,900 | $3,172,000 | 2.35% |
| Motley Fool Asset Management LLC | 259,000 | $10,412,000 | 2.25% |
| ARK Investment Management | 127,563 | $5,128,000 | 1.48% |
| Motley Fool Wealth Management, LLC | 325,965 | $13,104,000 | 1.26% |
| PINNACLE ASSOCIATES LTD | 1,514,710 | $60,891,000 | 1.16% |
| Bellevue Group AG | 205,253 | $8,251,000 | 1.10% |